SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 30.63 CNY -1.83% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SonoScape Medical Corp
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Total Current Liabilities
ÂĄ893.7m
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Current Liabilities
ÂĄ588.2m
CAGR 3-Years
75%
CAGR 5-Years
65%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Current Liabilities
ÂĄ2.9B
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Current Liabilities
ÂĄ12.9B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Current Liabilities
ÂĄ1B
CAGR 3-Years
52%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Current Liabilities
ÂĄ5.8B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
13.2B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
49.55 CNY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Total Current Liabilities?
Total Current Liabilities
893.7m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Total Current Liabilities amounts to 893.7m CNY.

What is SonoScape Medical Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
8%

Over the last year, the Total Current Liabilities growth was 49%. The average annual Total Current Liabilities growth rates for SonoScape Medical Corp have been 24% over the past three years , 8% over the past five years .

Back to Top